ENTITY
Astellas Pharma

Astellas Pharma (4503 JP)

121
Analysis
Health CareJapan
Astellas Pharma Inc. is a pharmaceutical company committed to the therapeutic fields of Urology, Immunology including Transplantation and Infectious Diseases, Oncology, Neuroscience and DM Complications and Metabolic Diseases. With over 17,000 global employees, Astellas researches, develops, manufactures, and promotes its prescription drugs through subsidiaries in the US, Europe, and Asia
more
Refresh
bullishAstellas Pharma
06 Apr 2017 18:22

Astellas (4503) Implications of Ogeda Acquisition

At first glance, Astellas Pharma's decision to buy closely-held Belgian biotech firm Ogeda for ¥90bil (US$800mil) is essentially a licensing deal...

17 Mar 2017 16:02

The Week That Was in NorthAsia@Smartkarma

This is the third report of "The Week That Was in North Asia@Smartkarma". This is a collaborative report among Mio Kato, CFA, Sanghyun Park,...

Logo
Mio Kato
338 Views
Share
12 Mar 2017 15:15

The Week That Was in NorthAsia@Smartkarma

This is the second report of "The Week That Was in North Asia@Smartkarma". This is a collaborative report among Travis Lundy, Mio Kato, CFA,...

Logo
269 Views
Share
04 Mar 2017 11:12

The Week That Was in NorthAsia@Smartkarma - Jelly Drinks, Dental Implants, & Tires

This is the inaugural report of "The Week That Was in North Asia@Smartkarma. This is a collaborative report among Travis Lundy, Mio Kato, CFA,...

Logo
283 Views
Share
27 Feb 2017 14:28

AI & Machine Learning Disrupting The Healthcare Industry

In the omnipresence of machine learning, one of the most impacted segments is healthcare. Not only is AI in healthcare at the forefront of a...

Logo
595 Views
Share
x